DK1007559T3 - Genetisk manipulerede celler, som udtrykker knoglemorfogene proteiner - Google Patents

Genetisk manipulerede celler, som udtrykker knoglemorfogene proteiner

Info

Publication number
DK1007559T3
DK1007559T3 DK98945924T DK98945924T DK1007559T3 DK 1007559 T3 DK1007559 T3 DK 1007559T3 DK 98945924 T DK98945924 T DK 98945924T DK 98945924 T DK98945924 T DK 98945924T DK 1007559 T3 DK1007559 T3 DK 1007559T3
Authority
DK
Denmark
Prior art keywords
cells expressing
genetically engineered
engineered cells
bone morphogenic
morphogenic proteins
Prior art date
Application number
DK98945924T
Other languages
Danish (da)
English (en)
Inventor
Gadi Turgeman
Ioannis Moutsatsos
Dan Gazit
Yoram Zilberman
Original Assignee
Inst Genetics Llc
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Genetics Llc, Yissum Res Dev Co filed Critical Inst Genetics Llc
Application granted granted Critical
Publication of DK1007559T3 publication Critical patent/DK1007559T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK98945924T 1997-09-05 1998-09-04 Genetisk manipulerede celler, som udtrykker knoglemorfogene proteiner DK1007559T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5798997P 1997-09-05 1997-09-05
US09/148,234 US20020102728A1 (en) 1997-09-05 1998-09-04 Genetically engineered cells which express bone morphogenetic proteins

Publications (1)

Publication Number Publication Date
DK1007559T3 true DK1007559T3 (da) 2006-05-08

Family

ID=22013954

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98945924T DK1007559T3 (da) 1997-09-05 1998-09-04 Genetisk manipulerede celler, som udtrykker knoglemorfogene proteiner

Country Status (12)

Country Link
US (2) US20020102728A1 (pt)
EP (1) EP1007559B1 (pt)
JP (1) JP2001514026A (pt)
AT (1) ATE314390T1 (pt)
AU (1) AU752556B2 (pt)
CA (1) CA2301882A1 (pt)
DE (1) DE69832989T2 (pt)
DK (1) DK1007559T3 (pt)
ES (1) ES2255180T3 (pt)
MX (1) MXPA00002318A (pt)
PT (1) PT1007559E (pt)
WO (1) WO1999011664A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030039695A1 (en) * 2001-08-10 2003-02-27 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Collagen carrier of therapeutic genetic material, and method
US8858981B2 (en) 1997-10-10 2014-10-14 Ed. Geistlich Soehne Fuer Chemistrie Industrie Bone healing material comprising matrix carrying bone-forming cells
US9034315B2 (en) 1997-10-10 2015-05-19 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Cell-charged multi-layer collagen membrane
US20050186283A1 (en) 1997-10-10 2005-08-25 Ed. Geistlich Soehne Ag Fuer Chemistrie Industrie Collagen carrier of therapeutic genetic material, and method
WO2001008714A1 (en) * 1999-07-28 2001-02-08 Regeneration Technologies, Inc. Cartilage or bone matrix as a nucleic acid delivery vehicle
US6939540B1 (en) 2000-07-31 2005-09-06 Cornell Research Foundation, Inc. Method of enhancing bone density
WO2003013588A1 (fr) * 2001-08-08 2003-02-20 Kaken Pharmaceutical Co., Ltd. Materiau de regeneration de rein comprenant des cellules et un facteur de croissance cellulaire
JP4097544B2 (ja) * 2003-02-27 2008-06-11 独立行政法人理化学研究所 人工リンパ節
WO2005004886A1 (en) * 2003-07-09 2005-01-20 Sdgi Holdings, Inc. Isolation of bone marrow fraction rich in connective tissue growth components and the use thereof to promote connective tissue formation
US20050272678A1 (en) * 2004-02-11 2005-12-08 Bodine Peter Van N BMP-6 estrogen responsive element and methods of use thereof
US7531355B2 (en) * 2005-07-29 2009-05-12 The Regents Of The University Of California Methods and compositions for smooth muscle reconstruction
WO2011060357A2 (en) * 2009-11-16 2011-05-19 The Ohio State University Engineered xenogeneic cells for repair of biological tissue
WO2017062511A1 (en) 2015-10-05 2017-04-13 Salk Instutitute For Biological Studies Synthetic adenoviruses with tropism to damaged tissue for use in promoting wound repair and tissue regeneration

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5942496A (en) * 1994-02-18 1999-08-24 The Regent Of The University Of Michigan Methods and compositions for multiple gene transfer into bone cells
US5763416A (en) * 1994-02-18 1998-06-09 The Regent Of The University Of Michigan Gene transfer into bone cells and tissues
WO1996039431A1 (en) * 1995-06-06 1996-12-12 Human Genome Sciences, Inc. Bone morphogenic protein-10

Also Published As

Publication number Publication date
ATE314390T1 (de) 2006-01-15
AU752556B2 (en) 2002-09-19
CA2301882A1 (en) 1999-03-11
DE69832989D1 (de) 2006-02-02
PT1007559E (pt) 2006-05-31
MXPA00002318A (es) 2006-02-22
US20020102728A1 (en) 2002-08-01
EP1007559B1 (en) 2005-12-28
WO1999011664A1 (en) 1999-03-11
DE69832989T2 (de) 2006-08-24
AU9306298A (en) 1999-03-22
ES2255180T3 (es) 2006-06-16
JP2001514026A (ja) 2001-09-11
US20110111505A1 (en) 2011-05-12
EP1007559A1 (en) 2000-06-14

Similar Documents

Publication Publication Date Title
DK1007559T3 (da) Genetisk manipulerede celler, som udtrykker knoglemorfogene proteiner
ATE404583T1 (de) Funktionelle antagonisten von hedgehog-aktivität
IL134042A0 (en) Modified dorsal tissue affecting factor and compositions
DK1100529T3 (da) Thymosin beta 4 fremmer sårheling
ATE391778T1 (de) Mutanten des vaskulären, endothelzellen- spezifischen wachstumsfaktors c (vegf-c) und deren verwendungen
DK0814827T3 (da) Karendotel-vækstfaktor-B
WO1999046366A8 (en) Uses for humane non-autologous mesenchymal stem cells
WO1999035262A3 (en) Apoptosis inducing molecule ii
NZ500577A (en) Human cerberus protein that regulates cell function, induce neural development or antagonise bone morphogenic proteins
FI971896A0 (fi) BMP-tyyppi II-reseptoria koodaava cDNA
WO1999049038A3 (en) Human calcium-binding proteins
WO2002050111A3 (en) Isolated laminin 10
WO2000066731A3 (en) Recombinant laminin 5
WO2000066732A3 (en) Laminin 8 and methods for its use
HK1002284A1 (en) Novel implant and novel vector for the treatment of acquired diseases
WO2000071078A3 (fr) Composition destinee a la mise en oeuvre d'un traitement antitumoral ou antiviral chez un mammifere
DK0745122T3 (da) Galninreceptor, nukleinsyrer, transformerede celler og anvendelser heraf
ATE302021T1 (de) Gefriergetrocknete zusammensetzung des menschlichen,morphogenen knochenproteins mp52
WO2000061774A3 (en) Bone morphogenic proteins
NZ506776A (en) Modulators of the function of receptors of the tnf/ngf receptor family and other proteins
WO2001040257A3 (en) Modified il-12 subunits and nucleic acids encoding them
WO2000074629A3 (fr) Composition destinee a la mise en oeuvre d'un traitement cytotoxique, notamment antitumoral ou antiviral, chez un mammifere
Carlson-Mann et al. Ridge augmentation with guided bone regeneration and GTAM case illustrations.
WO2001000662A3 (en) The use of human fgh-8 polypeptides as neurotrophic agents
EP0771877A4 (en) MODIFIED MORPHOGENIC PROTEIN RECEPTOR IN BONE CODING GENE